FLETCHER-FLORA HEALTH CARE SYSTEMS INTRODUCES
FFLEXCONNECT™ MIDDLEWARE

ANAHEIM, CA – September 1, 2006 – Answering the call for improved technology and connectivity in growing clinical labs with remote facilities, Fletcher-Flora Health Care Systems, Inc. (OTC:FFLH) announced today the release of FFlexConnect™, its new interface middleware/engine used to seamlessly integrate Fletcher-Flora's suite of Laboratory Information Systems (LIS) with remote lab locations. Key to its design, FFlexConnect™ uses secure Internet technology to manage the transfer of information between local or remote workstations and the LIS server in the main lab. It supports communication and manages the flow of information between an encaLaber® LIS and printers, label writers, devices, instruments and third-party clinical system interfaces.

“With encaLaber®, our customers already enjoy the many benefits of a robust Web-based LIS,” explained Neal Flora, President and CEO of Fletcher-Flora Health Care Systems, Inc. “FFlexconnect™ enhances encaLaber® by eliminating obstacles related to managing multiple devices in multiple locations. Essentially, with FFlexConnect™ we can connect encaLaber® to any system anywhere in the world with a high-speed Internet or LAN/WAN connection.”

FFlexConnect™ is integrated with encaLaber® and comes standard with each implementation or added remote location. For more information, please contact 1-800-7771471.

About Fletcher-Flora

For more than 20 years, Fletcher Flora Healthcare Systems, Inc., (OTC:PINK FFLH) has developed and marketed Laboratory Information Systems for physician offices, group practices and hospital laboratories. The company has grown to become a leader in both the non-hospital market and hospital market.  With its LabPak® line of products, Fletcher-Flora has successfully installed more than 1,400 systems in physician office laboratories, group practices, clinics and small hospitals. For more information about the Fletcher-Flora product suite, please contact Steve Fogle at (800) 777-1471 Ext: 234 or email steve@labpak.com. .

-- END --

 Statements contained in this press release, which are not historical facts, are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based largely on Fletcher-Flora Healthcare Systems’ expectations and are subject to a number of risks and uncertainties beyond Fletcher-Flora's control, including, but not limited to, economic, competitive and other factors affecting Fletcher-Flora's operations, management team effectiveness, expansion strategies, available financing, market prices and recovery costs, government regulations involving Fletcher-Flora and facts and events not known at the time of this release. These statements are not guarantees of future performance, and readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release.